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HEALTH TECHNOLOGY ASSESSMENT IN DEVELOPING COUNTRIES: 
WHAT IS THE STATE OF PLAY?
Shankland B, Mendes da Costa S
Double Helix Consulting, London, UK
OBJECTIVES: Health Technology (HTA) groups play an important role in health care
decision-making in the developed world. Previous studies have suggested that their 
impact is dependent on certain internal and external markers of capability. It is unclear 
if these markers are applicable to so-called ‘developing countries’. METHODS: A total 
of 122 respondents in 20 middle-income countries were interviewed over a 9-month 
period in 2008. The sample comprised health economists (27%), medical practitioners
(19%); health care decision makers with knowledge of pharmacoeconomics (26%),
and technology suppliers (28%). Health economists were surveyed about their group’s
preferred methodology of analysis, sources, therapeutic areas of interest and end cus-
tomers. Clinical and ﬁ nancial decision- makers were surveyed about their use of 
pharmacoeconomics in treatment and coverage decisions; relationships with stake-
holders; and other decision criteria. Technology suppliers were surveyed about formal 
and informal interactions with decision makers and their pharmacoeconomic require-
ments. A metric with three weighted variables was created. The variable measured
the technical sophistication of HTA groups according to a series of methodological 
markers; the second variable measured decision making transparency according to a
series of process markers; additionally, a third variable measured external environ-
mental factors impacting technology adoption. An adapted Boston Matrix was created
from these three variables. HTA groups in the Matrix were classiﬁ ed as ‘advanced’;
‘intermediate’; and ‘nascent’. RESULTS: Only 9% of the HTA groups surveyed quali-
ﬁ ed as ‘advanced’, and 23% of HTA groups qualiﬁ ed as ‘nascent’. A majority (68%) 
qualiﬁ ed as ‘intermediate’, suggesting a relationship to decision making despite great
diversity in their technical capabilities. Correlations between environmental factors 
and technical sophistication, but not process transparency, were observed. CONCLU-
SIONS: The technical sophistication of HTA groups varies widely in developing 
countries and is independent of conventional process and environmental markers.
Further research is needed to establish the additional drivers of HTA development in 
each country.
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RED BLOOD CELL TRANSFUSION PRACTICES IN VA INTENSIVE
CARE UNITS: HOW DO THEY VARY FOR PATIENTS WITH HEART AND
CHRONIC KIDNEY DISEASE?
Ding YY1, Berlowitz DR2, Kader B2, Christiansen CL2
1Tan Tock Seng Hospital, and National Healthcare Group Health Services & Outcomes
Research, Singapore, Singapore, 2Center for Health Quality, Outcomes & Economic Research, 
Bedford VA Hospital, Bedford, MA, Bedford, MA, USA
OBJECTIVES: Red blood cell (RBC) transfusions are commonly administered in the
care of critically ill patients. However, it is less clear how transfusion practice varies 
with hemoglobin (Hgb) level and with presence of heart and chronic kidney disease. 
We sought to describe the frequency of RBC transfusions among critically ill patients, 
how it varies with Hgb level, and to identify other associated patient characteristics. 
METHODS: This was a retrospective observational study involving secondary analy-
sis of administrative data of patients admitted to Veterans Affairs (VA) intensive care 
units (ICU) from 2001 to 2005. First ICU admissions of the year for unique patients 
were included. The outcome of interest was RBC transfusion during the ﬁ rst 30 days
of ICU admission. Explanatory variables include demographic and admission-related
information, Hgb level, co-morbid conditions, ICU admission diagnosis, and labora-
tory test results. Logistic regression modeling quantiﬁ ed associations between these 
variables and transfusion. RESULTS: The data of 259,281 admissions were analyzed.
Overall incidence of RBC transfusion was 12.5%, varying from 0.6% for Hgb above 
12 g/dl, to 68.0% for Hgb below 5 g/dl. Increased age (OR 1.05, 95%CI 1.03–1.06 
every 10 years), male gender (OR 1.19, 95%CI 1.08–1.30), admission for acute
myocardial infarction (AMI) (OR 1.28, 95%CI 1.21–1.36), and co-morbid heart 
disease (OR 1.05, 95%CI 1.02–1.09) were independently associated with transfusion,
but chronic kidney disease was not. Signiﬁ cant interactions between Hgb level and 3 
admission diagnoses (AMI, angina, and congestive heart failure) resulted in even
higher likelihood of transfusion among patients admitted for these conditions and had 
lower Hgb levels. CONCLUSIONS: Independent of Hgb level, ICU patients admitted 
for AMI, angina or congestive heart failure had higher likelihood of RBC transfusion,
with this likelihood increasing even further among those with lower Hgb levels.
Further research is needed to determine how these practices inﬂ uence outcomes.
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PHYSICIAN KNOWLEDGE AND CONFIDENCE IN APPROPRIATE
MEDICATION PRESCRIBING IN THE ELDERLY: A SURVEY STUDY IN
PARMA, ITALY
Maio V1, Abouzaid S1, Negri G2, Donatini A3
1Thomas Jefferson University, Philadelphia, PA, USA, 2LHU Parma, Parma, Parma, Italy, 3LHU 
Parma, Parma, Italy
OBJECTIVES: To assess general practitioners’ (GPs) conﬁ dence in and knowledge of 
appropriate medication prescribing in elderly patients. METHODS: A total of 155 GPs 
(51% of the total number of GPs convened by the Local Health Unit (LHU) of 
Parma for an educational session), were asked to complete anonymously a 21-item
paper survey. Physician demographics were collected. Conﬁ dence in prescribing for
the elderly was measured using a 5-point Likert scale. Knowledge of inappropriate
medication use in the elderly was assessed using 7 clinical vignettes based on the 2003 
Beers Criteria, and a score out of 7 was assigned depending on the number of correct
responses. Topics tested included hypertension, osteoarthritis, arrhythmias, insomnia, 
and depression. Data regarding physician’s perceived barriers to appropriate prescrib-
ing for elderly patients was collected. Descriptive analyses using Fisher’s exact test
and t-test were conducted as appropriate. RESULTS: All GPs completed the survey. 
Respondents were 76% male, had a mean age of 54 (SD o 5.0), and mean years in
practice of 22 (SD o 8.3). Most physicians (88%) felt conﬁ dent in their ability to pre-
scribe appropriate medications for the elderly. Sixty-nine percent of physicians had 
never heard of the Beers Criteria for potentially inappropriate prescribing in the
elderly. The mean score in the clinical vignettes was 4.6 (SD o 1.3). Comparison of 
characteristics of lower score (a3) respondents versus higher score (q6) respondents 
revealed that the former have been in practice for a longer time (p  0.005). Perceived 
barriers to appropriate prescribing included potential drug interactions (79% of 
respondents) and the large number of medications a patient is already taking (75%). 
CONCLUSIONS: While the majority of GPs feel conﬁ dent in their prescribing for 
elderly patients, there is room for improvement regarding their knowledge of appropri-
ate prescribing. Educational strategies tailored to speciﬁ c GPs’ categories should be
establish to enhance knowledge in this area and improve quality of prescribing.
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25 YEARS OF ECONOMIC EVALUATION IN MEXICO: A SYSTEMATIC
REVIEW OF ARTICLES PUBLISHED IN THE ECONOMIC AND MEDICAL
LITERATURE: 1984–2009
Mould-Quevedo J1, Contreras-Hernandez I2
1Pﬁ zer Mexico, Mexico City, Mexico, 2Social Security Mexican Institute, Mexico City, Mexico
OBJECTIVES: To assess the state of the art of economic evaluations (EE) of health 
care programs researches in Mexico, regarding their methodological quality and 
current tendencies. METHODS: Systematic review of Mexican studies on EE in health, 
published in national and international journals from January 1984(ﬁ rst Mexican 
article published) to January 2009. We searched multiple electronic databases 
(PubMed, Embase, Mediagraphic, Imbiomed, Latinmed), hand-searched key journals 
and personally contacted investigators in January 2009. Two health economist review-
ers independently assessed the relevance of retrieved articles, described the methods 
of included studies and extracted data that was summarized by consensus. Drum-
mond’s criteria were used: a) to classify between complete economic evaluation (CEE)
or partial economic evaluation (PEE), and b) to assess the criteria quality of methodol-
ogy. Publication characteristics analyses were conducted with descriptive and analytic
statistics. Limitation: only published studies in journals were included(abstracts, book
chapters or technical reports were excluded). RESULTS: A total of 101 studies
matched inclusion criteria: 48.5% were CEE and 51.5% were PEE. Number of 
CEEs in Mexico increased signiﬁ cantly among 2005–2009(14 studies), showing a
71.8% increase in all EE. A total of 73.3% of manuscripts were published in Mexican 
Journals and 81.6% corresponded to cost-effectiveness analyses. Articles covered 
emphasis on nephrology (9.0%) and infectology (8.4%). Regarding 2008–2009 
methodology quality improvement in comparison to 2004 publications: 40.8% 
didn’t mention study perspective (vs.66.7% in 2004, p  0.05), 44.9% didn’t report 
sensitivity analyses (vs.66.7% in 2004, p  0.05), 30.0% didn’t report discount rate
when it was necessary(vs.63.5% in 2004, p  0.05) and only 40.8% studies estimated 
an ICER (vs.37.5% in 2004, p  0.12). During 1984–2009, only 28.6% of published
studies reported probabilistic sensitivity analyses and 18.4% used a decision tree-
model in the assessment(main economic model used). CONCLUSIONS: An increase 
in CEEs in Mexico with a small improvement on quality methodology during the last
ﬁ ve-year period.
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MEXICAN POSTER PRESENTATIONS AT ISPOR MEETINGS: 
A QUALITY AND TENDENCY ASSESSMENT 2003–2008
Mould-Quevedo J1, Contreras-Hernandez I2
1Pﬁ zer Mexico, Mexico City, Mexico, 2Social Security Mexican Institute, Mexico City, Mexico
OBJECTIVES: To assess the state of the art of Mexican pharmacoeconomics (PE) and 
outcomes research (OR) poster presentations at International Society for Pharmaco-
economics and Outcomes Research(ISPOR) meetings, regarding methodological 
quality and current tendencies. METHODS: Systematic review of Mexican presenta-
tions on PE and OR at ISPOR Meetings from May 2003 (ﬁ rst Mexican poster pre-
sentation) to November 2008. We searched abstracts and poster presentations at
Annual International Meetings, Annual European Congresses and Latin America
Conferences. Two health economist reviewers assessed the relevance of retrieved 
abstracts, described the methods of included studies and extracted data that was sum-
marized by consensus. Drummond’s criteria were used: a) to classify between complete 
economic evaluation (CEE) or partial economic evaluation; and b) to assess the criteria 
quality of methodology. Abstracts characteristics analyses were conducted with 
descriptive and analytic statistics. RESULTS: A total of 116 abstracts matched inclu-
sion criteria: 97 were PE (83.6%), 13 were OR (11.2%) and 6 were clinical trials 
results (5.2%). A total of 82.5% of PE abstracts were CEE. During the past two years
presentations increased signiﬁ cantly(16 studies), showing an 88.9% growth. A total
of 60.3% of studies were performed at the Social Security Mexican Institute(IMSS) 
and 70.1% of PE presentations corresponded to cost-effectiveness analyses. Posters 
covered a wide range of conditions, with emphasis on cardiovascular diseases (19.8%) 
and oncology (12.1%). Regarding quality of CEE studies: 27.4% didn’t mention study 
perspective, 40.3% didn’t report analyses, 39.1% didn’t report discount rate when it 
was necessary(time horizon above 1-year) and only 52.6% studies estimated an ICER.
A total of 69.0% of these studies had a pharmaceutical-industry sponsor, 34.5% were
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performed by Mexican private consultants and 67.6% of the CEE presentations used
a decision tree-model or a Markov model. CONCLUSIONS: An increase of Mexican 
presentations at ISPOR meetings mainly promoted by local consultants and pharma-
ceutical companies with a medium methodological quality.
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THE STATUS QUO OF THE USAGE OF CHINESE VERSIONS OF
GENERIC HEALTH-RELATED QUALITY OF LIFE INSTRUMENTS
Li MH1, Liu G2, Luo N3
1China Pharmaceutical University, Nanjing, Jiangsu, China, 2Peking University, Beijing, Beijing, 
China, 3National University of Singapore, Singapore, Singapore
OBJECTIVES: In order to assess health-related quality of life (HRQoL) among
Chinese-speaking populations, a number of HRQoL instruments originally developed
in English in North America or Europe were translated into Chinese over the past two
decades. The current study attempted to review the usage of Chinese versions of 
generic HRQoL instruments including SF-36, SF-12, SF-8, SF-6D, EQ-5D, HUI2,
HUI3, and QWB. METHODS: MEDLINE and ﬁ ve Chinese databases including CNKI 
(mainland China), CBM (mainland China), Wanfang (mainland China), CEPS
(Taiwan), and HKInChiP (Hong Kong & Macau) were searched up to December 2008
for HRQoL studies in Chinese-speaking populations. RESULTS: A total of 1341 rel-
evant original research papers were identiﬁ ed. Approximately three-quarters (73.90%)
of papers were published in Chinese journals. The vast majority of papers (91.50%) 
were published after the year of 2002. In terms of the number of papers, the top three
frequently used generic HRQoL instruments were SF-36 (n  1281), EQ-5D (n  30),
and SF-12 (n  28). One thousand and sixty-two papers reported HRQoL measured
in patient populations, with circulatory diseases being the most frequently studied 
therapeutic areas (n  195). Geographically, identiﬁ ed studies were mainly conducted 
in mainland China (n  1012), followed by Taiwan (n  149), Hong Kong (n  112), 
Singapore (n  53), U.S. (n  10), Canada (n  4) and Australia (n  1). Except for 
Singapore where the majority of studies were used to evaluate instruments, generic 
HRQoL instruments were mainly used to measure quality of life in other countries or 
districts. CONCLUSIONS: There is a growing body of English and Chinese literature 
on the measurement of HRQoL using generic HRQoL instruments in Chinese-
speaking populations. For better assessment of Chinese-speaking populations, the
appropriateness of existing generic HRQoL instruments should be further evaluated
in the future.
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ASSESSING THE QUALITY OF CARE IN ITALY’S PRIMARY CARE
PRACTICES USING ADMINISTRATIVE DATA. IS IT FEASIBLE?
Maio V1, Bassi MB2, Abouzaid S1, Pinotti M2, Riccò D2
1Thomas Jefferson University, Philadelphia, PA, USA, 2LHU Reggio Emilia, Reggio Emilia, Italy
OBJECTIVES: To develop process indicators for assessing the quality of care in the
23 Primary Care Groups (PCGs) of the Local Health Unit (LHU) of Reggio Emilia,
Italy, using administrative data. METHODS: Data were extracted from the 2006 
Reggio Emilia LHU Healthcare database, including demographic, hospital, outpatient 
pharmacy, and outpatient specialty data on all residents, as well as information about 
each LHU General Practitioner (GP). We retrieved information on approximately
450,000 LHU residents and on 343 GPs and their PCG of practice. We included GPs
who practiced for the whole year in only one PCG. The sample patient population
comprised individuals who were residents in the LHU for the whole year and did
not change their GP during the year. Initially developed based on a literature review,
the quality indicators were deﬁ ned jointly by the project team and leaders of the 23
PCGs. For each indicator, we computed the proportion of eligible patients within each 
PCG who received the recommended care. RESULTS: A total of 340 GPs (99.1%)
met the inclusion criteria. These GPs had a total number of 383,772 continuously 
enrolled patients for 2006. The number of GPs per PCG ranged from 4 to 28 and the
number of patients per PCG varied from 3,862 to 30,855. Nine quality care indicators
covering cardiovascular, diabetes, and asthma management were identiﬁ ed. Analyses 
of the indicators exhibited signiﬁ cant variation among the PCGs. For example, the
proportion of post-myocardial infarction patients receiving beta-blockers varied from 
33.3% to 90.9% across the PCGs. CONCLUSIONS: Quality of care provided by
Italy’s family physician practices can be assessed using administrative data. For the
indicators adopted, study ﬁ ndings showed a considerable variation in medical patterns 
among PCGs. These results provide LHU policy makers and PCGs with relevant
information to establish quality improvement initiatives targeted at the individual 
practice level.
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AN EVALUATION OF PHARMACOECONOMICS EDUCATION 
IN COLLEGES OF PHARMACY OUTSIDE THE UNITED STATES
2007–2008 UPDATE
Reddy M, Rascati KL, Wilson JP, Nwo Keji ED
University of Texas at Austin, Austin, TX, USA
OBJECTIVES: The purpose of the study was to measure the extent of pharmacoeco-
nomics education (PE) in non-US colleges of pharmacy. METHODS: Two surveys
were used. Survey 1 was e-mailed or faxed to over 700 colleges of pharmacy, obtained 
from the International Pharmaceutical Federation Website or through Medline and
Google Searches, asking respondents if pharmacoeconomics was taught in their 
college. Survey 2 was sent to respondents who taught PE asking: 1) number of class-
room hours devoted to PE 2) whether these were in a required or elective course 3)
number of students in the course 4) topics covered 5) resources (books/articles) used.
RESULTS: Ninety-eight schools responded to Survey 1. Pharmacoeconomics educa-
tion was offered at 62 (63%) of these 98 colleges. The response rate for Survey 2 was 
52% (n  33). However 3 colleges did not provide complete data, leaving data on 30
colleges for this analysis. Twenty-six (87%) colleges indicated that pharmacoeconom-
ics was taught as a required course, 2 (7%) indicated that it was offered as an elective 
course, and 2 (7%) indicated that PE was taught as both a required and elective course. 
The median number of required hours was 16 (std dev  150). The number of elective 
hours ranged from 3 to 45 with a median of 27 (std dev  19). The mean number of 
students taking pharmacoeconomics as a required course was 104 (std dev  60; 
median  90, range 12–250). “Types of pharmacoeconomic analyses” (i.e., comparing
CBA, CEA, CMA, CUA) was the most common topic taught. Several articles and 
books were provided as resources. A comparison of these results to similar studies
conducted previously will be provided. CONCLUSIONS: Correct and current contact 
information for international pharmacy schools was difﬁ cult to obtain, and obtaining 
high response rates was also challenging. In this study, both e-mails and facsimiles
were used to increase response rates.
HEALTH CARE USE & POLICY STUDIES – Health Technology
Assessment Programs
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ADDRESSING THE CHALLENGE OF IMPLEMENTING HEALTH 
TECHNOLOGIES: THE SPANISH EXPERIENCE
Paz S1, Lizan L1, Rodriguez JM2, Anton E2
1Jaume I University, Castellon, Spain, 2Medtronic Iberia, Madrid, Spain
OBJECTIVES: To explore the present the process followed to implement technologies 
in the public health sector from the perspective of key decision makers. The Spanish
National Health System (NHS) is decentralized, and most management is decided in
the seventeen Autonomous Communities (AC). Several health technology evaluation
agencies (HTEA) have been established countrywide. The literature shows that 
im plementation ‘technologies’ remains far from ideal in Spain (Gonzalez B, 2007).
METHODS: A naturalistic, qualitative study was conducted. Semi-structured inter-
views with key decision makers across country, including senior health managers at
the Autonomous Communities’ Departments of Health (macro-level of decision), 
Hospitals’ managers and directors (meso-level), Heads of clinical services (micro-level 
of decision), and experts on health services’ research and evaluation were carried out 
to explore their views on the present of the implementation of technologies in the 
health system. Data interviews data were collected until different categories of infor-
mation was saturated. The grounded theory method was applied to categorize the 
information gathered. RESULTS: A total of 35 interviews were conducted, including 
managers, researchers and evaluators. Eight categories of information emerged: 1) the 
industry’s inputs to the NHS, contributing to its modernization; 2) the assessment of 
technologies, based on safety and efﬁ cacy while leaving behind effectiveness, efﬁ ciency 
or cost-beneﬁ t; 3) implementation processes, relying on informal mechanisms and 
variable criteria; 4) the gap, between legal statements and existing practices; 5) HTEA 
reports’, of scarce impact on managers’ decisions; 6) ﬁ nancing mechanisms, that one 
barely effective in responding to technological progresses; 7) the industry, seen as a 
self-centered NHS provider making little efforts to realistically show the “pros and
cons” of technologies; 8) the need for transparency, openness and consensus amongst
all involved. CONCLUSIONS: Major opportunities for improvement in the imple-
mentation of technologies in the NHS exist. These ﬁ ndings set the basis for exploring
strategies to enhance the future scenario.
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USE OF INDIRECT COMPARISON IN HTA SUBMISSIONS
Buckley F1, Modha R1, Muston D2, Misra A3, Williams R3
1Heron Evidence Development Ltd, Luton, UK, 2Heron Evidence Development Ltd, Stopsley, 
Luton, UK, 3Amgen, Inc., Thousand Oaks, CA, USA
OBJECTIVES: The quality of evidence used by manufacturers in submissions to HTA 
agencies is an important determinant of a positive appraisal. In 2008, NICE revised 
guidelines and added a section on indirect synthesis methods. The study objective was 
to evaluate previous trends and understand past and evolving inﬂ uences of method-
ological factors, particularly indirect and mixed treatment comparisons, on submission 
outcome. METHODS: A landscape review was conducted of NICE submission meth-
odologies and appraisal outcome, with focus on the use of indirect comparison. Key 
data were extracted from NICE/ ERG documents for all NICE appraisals (2003-
August 2008). Also, case studies were investigated in rheumatoid arthritis, osteopo-
rosis, bone metastases and oncology. Key ﬁ ndings and recommendations for submission 
preparation, with focus on indirect comparison use, are presented. RESULTS: The 
number of indirect comparisons used in appraisals has increased from 2 to 8 between
2005 and 2008. The proportions of published NICE appraisals mentioning indirect 
comparisons to total appraisals were 2/7 (2005), 2/18 (2006), 7/21 (2007) and August 
2/18 to August 2008. Indirect comparison, historically, used primarily in oncology, is 
increasingly being implemented in other therapeutic areas. However, 81% of NICE 
submissions that included indirect comparison have been recommended, compared 
with 86% that did not include indirect comparison. NICE critique of indirect com-
parisons across submissions focused on the lack of clear justiﬁ cation of methodology,
assumptions, and comparators used, along with management of clinical and statistical 
heterogeneity. Further, case studies have shown the need to avoid non-validated 
methods and distant indirect comparisons. CONCLUSIONS: Where head-to-head 
